YHLO iFlash-2019-nCoV Antigen Test applies the chemiluminescent immunosassay for the qualitative detection of SARS-COV-2 antigen in nasal swab or nasopharyngeal swab, which may deliver a reliable and accurate result with high sensitivity and specificity. Further more, as a fully automated and market-leading chemiluminescent analyzer, iFlash 1800/3000 is able to improve assay performance and avoid cross-infection to ensure the bio-safety during the whole operation.

Features：

• Reliable Result: High Sensitivity and Specificity
• High Throughput: Up to 300 T/h
• Full Automation: Automated workflow reduces manual operation and avoids cross-infection to make the operators safety.
• Reputation: iFlash CLIA solutions have been applied and evaluated by more than one hundred of published academic studies.